确定了肺癌的新型治疗标:线粒体核糖体蛋白L9
Xin-Yuan Li1, Xin-Yu He1, Hong Zhao2
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Pathology, research and practice
|June 21, 2023
概括
线粒体核糖体蛋白L9 (MRPL9) 在肺癌中升高,与生存率差相关. 抑制MRPL9可以减少癌细胞的生长和迁移,这表明它是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺癌仍然是癌症相关死亡的主要原因,其机制尚未完全理解.
- 开发新的治疗点对于改善肺癌患者的治疗结果至关重要.
研究的目的:
- 通过分析表达形状数据来确定肺癌的潜在治疗点.
- 研究线粒体核糖体蛋白L9 (MRPL9) 在肺癌进展中的作用及其与信号通路的关联.
主要方法:
- 肺癌表达特征数据的查和生存分析.
- 实验室内试验涉及对MRPL9进行淘汰,以评估其对癌细胞增殖,球形形成和迁移的影响.
- 生物信息学分析和实验验证,以探索MRPL9,c-MYC和表皮层-介质细胞转变 (EMT) 调节器之间的关联.
主要成果:
- 发现MRPL9在肺癌组织中被上调,并与整体和无复发生存率较差有关.
- 抑制MRPL9显著抑制了肺癌细胞的增殖,球形和迁移.
- MRPL9表达与c-MYC信号通路相关,MRPL9和MYC的联合高表达表明预后不佳.
- 确定c-MYC可以调节ZEB1,一种与EMT相关的蛋白质,通过实验操作进一步证实了这一点.
结论:
- MRPL9是肺癌的潜在治疗标.
- MRPL9通过影响c-MYC/ZEB1轴来发挥其致癌功能,从而影响EMT和癌症进展.
相关概念视频
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Mitochondrial Protein Sorting
4.4K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.4K
Translocation of Proteins into the Mitochondria
3.2K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K


